Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer’s Disease

@article{RodrguezRuiz2017HeteroreceptorCF,
  title={Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer’s Disease},
  author={Mar Rodr{\'i}guez-Ruiz and Estefan{\'i}a Moreno and David Moreno-Delgado and Gemma Navarro and Josefa Mallol and Antonio Cortés and Carmen Lluis and Enric I. Canela and Vicent Casad{\'o} and Peter J. McCormick and Rafael Franco},
  journal={Molecular Neurobiology},
  year={2017},
  volume={54},
  pages={4537-4550}
}
Alzheimer’s disease (AD) is a neurodegenerative disorder causing progressive memory loss and cognitive dysfunction. Anti-AD strategies targeting cell receptors consider them as isolated units. However, many cell surface receptors cooperate and physically contact each other forming complexes having different biochemical properties than individual receptors. We here report the discovery of dopamine D1, histamine H3, and N-methyl-D-aspartate (NMDA) glutamate receptor heteromers in heterologous… 

N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors

The expression of the CB 2 -NMDA receptor heteromers increases in both microglia and neurons from the APP Sw/Ind transgenic mice, compared with levels in samples from age-matched control mice, indicating a negative cross-talk in CB 2-NMDA complexes signaling.

Heteroreceptor Complexes Implicated in Parkinson’s Disease

This review deals mainly with the A2AR-D2R and A1R-D1R heteroreceptor complexes, their balance with dopamine and adenosine isoreceptor complex and their role in Parkinson’s disease and its treatment.

Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue

Investigating the putative α7 nAChR/NMDAR assembly in human and murine brain tissues supports the formation of the complex and presents new insights into its regulation in healthy and diseased brain tissue.

Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs

This review summarizes the functional and pharmacological characteristics of the dopamine D1 receptor (D1R) interactome constituted by heteromers with GPCRs or non-GPCRs, and proposes that drugs targeting specific D1R heteromers in the CNS will be more effective and safer, resulting in a reduction of side effects.

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

The review summarizes the recent advances in the field, addressing the relevance of emerging new targets in schizophrenia in particular in relation to the dopamine – glutamate NMDA systems interactions.

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization

Molecular dynamics simulations showed that, in contrast to the other antagonists, spiperone and haloperidol respectively increased the atomic distance between reference α carbon atoms of transmembrane domains IV and V and I and II, both of which provide key interfaces for D3R dimerization.

Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer's Disease.

The state-of-art regarding genetic, neuropathology and neurochemistry of AD involving monoamine systems are reviewed and the effects of monoamines found in the brain of mammals as well as the reported effects of their derivatives and some structure-activity relationships are compiled.

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

The detected increased expression of GPR55-endocannabinoid heteromers appoints these GPCR complexes as potential non-dopaminergic targets for PD therapy.

References

SHOWING 1-10 OF 44 REFERENCES

Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway*

The results indicate that D1-H3 receptor heteromers work as processors integrating dopamine- and histamine-related signals involved in controlling the function of striatal neurons of the direct striatal pathway.

Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers*

It is shown that SKF81297, a selective D1/D5 receptor agonist, prevented the reduction in surface levels of AMPA and NMDA receptors induced by AβOs in hippocampal neurons in culture, and suggest that D1-D5 receptors may be relevant targets for development of novel pharmacological approaches to prevent synapse failure in AD.

Regulation of Dopamine D1 Receptor Trafficking and Desensitization by Oligomerization with Glutamate N-Methyl-D-aspartate Receptors*

It is reported that, in striatal neurons, D1 receptors are co-localized with N-methyl-d-aspartate (NMDA) receptors in the postsynaptic density and that they co-immunoprecipitate with NMDA receptor subunits from post Synaptic density preparations.

Cocaine Disrupts Histamine H3 Receptor Modulation of Dopamine D1 Receptor Signaling: σ1-D1-H3 Receptor Complexes as Key Targets for Reducing Cocaine's Effects

It is shown that blockade of σ1 receptor by an antagonist restores the protective H3 receptor-mediated brake on D1 receptors signaling and prevents the cell death from elevated D1 receptor signaling, suggesting that a combination therapy of ρ1R antagonists with H3 receptors agonists could serve to reduce some effects of cocaine.

D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade*

In cells transfected with a catalytically defective mutant of MEK1, the upstream ERK-specific kinase, both dopamine- and SKF R-38393-mediated cytotoxicity was markedly attenuated, confirming the participation of the ERK signaling pathway.

Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers

The mechanism by which the initial exposure to cocaine can inhibit signaling via D2 receptor containing neurons, destabilizing the delicate signaling balance influencing drug seeking that emanates from the D1 and D2 receptors containing neurons in the brain is illuminated.

Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine

The results provide a molecular explanation for which D1R plays a more significant role in the behavioral effects of cocaine, through σ1R-D1R heteromerization, and provide a unique perspective toward understanding the molecular basis of cocaine addiction.